|
WO2021048400A1
|
|
Method for identifying t-cell epitopes
|
|
WO2021048381A1
|
|
Method for identifying stable mhc binding peptides using mass spectrometry
|
|
WO2020182901A1
|
|
Nucleic acid vaccination using neo-epitope encoding constructs
|
|
WO2020174044A1
|
|
Vaccines targeting h. influenzae
|
|
WO2020141207A1
|
|
Vaccines targeting neoepitopes
|
|
WO2020083904A1
|
|
Vaccines targeting m. catharrhalis
|
|
WO2019145399A1
|
|
Vaccines for prophylaxis of s. aureus infections
|
|
WO2018127545A1
|
|
Vaccines targeting pseudomonas aeruginosa
|
|
WO2018015575A1
|
|
Chimeric proteins for inducing immunity towards infection with s. aureus
|
|
WO2017220787A1
|
|
Vaccines against aearomonas salmonicida infection
|
|
WO2017216384A1
|
|
Vaccination targeting ichthyophthirius multifiliis
|
|
EP3419654A1
|
|
Proteins and nucleic acids useful in vaccines targeting staphylococcus aureus
|
|
EP3317295A1
|
|
Proteins and nucleic acids useful in vaccines targeting pseudomonas aeruginosa
|
|
US2016168208A1
|
|
Peptides derived from Campylobacter jejuni and their use in vaccination
|
|
US2019015496A1
|
|
Proteins and nucleic acids useful in vaccines targeting Klebsiella pneumoniae
|
|
US2018169211A1
|
|
Peptides derived from acinetobacter baumannii and their use in vaccination
|
|
EP3077820A1
|
|
Proteins and nucleic acids useful in vaccines targeting staphylococcus aureus
|
|
EP2694534A1
|
|
Proteins and nucleic acids useful in vaccines targeting staphylococcus aureus
|
